172 related articles for article (PubMed ID: 28440912)
1. Performance of in silico tools for the evaluation of p16INK4a (CDKN2A) variants in CAGI.
Carraro M; Minervini G; Giollo M; Bromberg Y; Capriotti E; Casadio R; Dunbrack R; Elefanti L; Fariselli P; Ferrari C; Gough J; Katsonis P; Leonardi E; Lichtarge O; Menin C; Martelli PL; Niroula A; Pal LR; Repo S; Scaini MC; Vihinen M; Wei Q; Xu Q; Yang Y; Yin Y; Zaucha J; Zhao H; Zhou Y; Brenner SE; Moult J; Tosatto SCE
Hum Mutat; 2017 Sep; 38(9):1042-1050. PubMed ID: 28440912
[TBL] [Abstract][Full Text] [Related]
2. Are machine learning based methods suited to address complex biological problems? Lessons from CAGI-5 challenges.
Savojardo C; Babbi G; Bovo S; Capriotti E; Martelli PL; Casadio R
Hum Mutat; 2019 Sep; 40(9):1455-1462. PubMed ID: 31066146
[TBL] [Abstract][Full Text] [Related]
3. Performance of computational methods for the evaluation of pericentriolar material 1 missense variants in CAGI-5.
Monzon AM; Carraro M; Chiricosta L; Reggiani F; Han J; Ozturk K; Wang Y; Miller M; Bromberg Y; Capriotti E; Savojardo C; Babbi G; Martelli PL; Casadio R; Katsonis P; Lichtarge O; Carter H; Kousi M; Katsanis N; Andreoletti G; Moult J; Brenner SE; Ferrari C; Leonardi E; Tosatto SCE
Hum Mutat; 2019 Sep; 40(9):1474-1485. PubMed ID: 31260570
[TBL] [Abstract][Full Text] [Related]
4. PON-P and PON-P2 predictor performance in CAGI challenges: Lessons learned.
Niroula A; Vihinen M
Hum Mutat; 2017 Sep; 38(9):1085-1091. PubMed ID: 28224672
[TBL] [Abstract][Full Text] [Related]
5. Blind prediction of deleterious amino acid variations with SNPs&GO.
Capriotti E; Martelli PL; Fariselli P; Casadio R
Hum Mutat; 2017 Sep; 38(9):1064-1071. PubMed ID: 28102005
[TBL] [Abstract][Full Text] [Related]
6. CAGI SickKids challenges: Assessment of phenotype and variant predictions derived from clinical and genomic data of children with undiagnosed diseases.
Kasak L; Hunter JM; Udani R; Bakolitsa C; Hu Z; Adhikari AN; Babbi G; Casadio R; Gough J; Guerrero RF; Jiang Y; Joseph T; Katsonis P; Kotte S; Kundu K; Lichtarge O; Martelli PL; Mooney SD; Moult J; Pal LR; Poitras J; Radivojac P; Rao A; Sivadasan N; Sunderam U; Saipradeep VG; Yin Y; Zaucha J; Brenner SE; Meyn MS
Hum Mutat; 2019 Sep; 40(9):1373-1391. PubMed ID: 31322791
[TBL] [Abstract][Full Text] [Related]
7. CDKN2A unclassified variants in familial malignant melanoma: combining functional and computational approaches for their assessment.
Scaini MC; Minervini G; Elefanti L; Ghiorzo P; Pastorino L; Tognazzo S; Agata S; Quaggio M; Zullato D; Bianchi-Scarrà G; Montagna M; D'Andrea E; Menin C; Tosatto SC
Hum Mutat; 2014 Jul; 35(7):828-40. PubMed ID: 24659262
[TBL] [Abstract][Full Text] [Related]
8. BRCA1- and BRCA2-specific in silico tools for variant interpretation in the CAGI 5 ENIGMA challenge.
Padilla N; Moles-Fernández A; Riera C; Montalban G; Özkan S; Ootes L; Bonache S; Díez O; Gutiérrez-Enríquez S; de la Cruz X
Hum Mutat; 2019 Sep; 40(9):1593-1611. PubMed ID: 31112341
[TBL] [Abstract][Full Text] [Related]
9. Germline
Jouenne F; Chauvot de Beauchene I; Bollaert E; Avril MF; Caron O; Ingster O; Lecesne A; Benusiglio P; Terrier P; Caumette V; Pissaloux D; de la Fouchardière A; Cabaret O; N'Diaye B; Velghe A; Bougeard G; Mann GJ; Koscielny S; Barrett JH; Harland M; Newton-Bishop J; Gruis N; Van Doorn R; Gauthier-Villars M; Pierron G; Stoppa-Lyonnet D; Coupier I; Guimbaud R; Delnatte C; Scoazec JY; Eggermont AM; Feunteun J; Tchertanov L; Demoulin JB; Frebourg T; Bressac-de Paillerets B
J Med Genet; 2017 Sep; 54(9):607-612. PubMed ID: 28592523
[TBL] [Abstract][Full Text] [Related]
10. CAGI5: Objective performance assessments of predictions based on the Evolutionary Action equation.
Katsonis P; Lichtarge O
Hum Mutat; 2019 Sep; 40(9):1436-1454. PubMed ID: 31317604
[TBL] [Abstract][Full Text] [Related]
11. Missense variant pathogenicity predictors generalize well across a range of function-specific prediction challenges.
Pejaver V; Mooney SD; Radivojac P
Hum Mutat; 2017 Sep; 38(9):1092-1108. PubMed ID: 28508593
[TBL] [Abstract][Full Text] [Related]
12. What went wrong with variant effect predictor performance for the PCM1 challenge.
Miller M; Wang Y; Bromberg Y
Hum Mutat; 2019 Sep; 40(9):1486-1494. PubMed ID: 31268618
[TBL] [Abstract][Full Text] [Related]
13. CDKN2A/P16INK4A variants association with breast cancer and their in-silico analysis.
Aftab A; Shahzad S; Hussain HMJ; Khan R; Irum S; Tabassum S
Breast Cancer; 2019 Jan; 26(1):11-28. PubMed ID: 30039340
[TBL] [Abstract][Full Text] [Related]
14. Cdkn2a encodes functional variation of p16INK4a but not p19ARF, which confers selection in mouse lung tumorigenesis.
Herzog CR; Noh S; Lantry LE; Guan KL; You M
Mol Carcinog; 1999 Jun; 25(2):92-8. PubMed ID: 10365910
[TBL] [Abstract][Full Text] [Related]
15. Assessing the performance of in silico methods for predicting the pathogenicity of variants in the gene CHEK2, among Hispanic females with breast cancer.
Voskanian A; Katsonis P; Lichtarge O; Pejaver V; Radivojac P; Mooney SD; Capriotti E; Bromberg Y; Wang Y; Miller M; Martelli PL; Savojardo C; Babbi G; Casadio R; Cao Y; Sun Y; Shen Y; Garg A; Pal D; Yu Y; Huff CD; Tavtigian SV; Young E; Neuhausen SL; Ziv E; Pal LR; Andreoletti G; Brenner SE; Kann MG
Hum Mutat; 2019 Sep; 40(9):1612-1622. PubMed ID: 31241222
[TBL] [Abstract][Full Text] [Related]
16. Reports from the fifth edition of CAGI: The Critical Assessment of Genome Interpretation.
Andreoletti G; Pal LR; Moult J; Brenner SE
Hum Mutat; 2019 Sep; 40(9):1197-1201. PubMed ID: 31334884
[TBL] [Abstract][Full Text] [Related]
17. Ensemble variant interpretation methods to predict enzyme activity and assign pathogenicity in the CAGI4 NAGLU (Human N-acetyl-glucosaminidase) and UBE2I (Human SUMO-ligase) challenges.
Yin Y; Kundu K; Pal LR; Moult J
Hum Mutat; 2017 Sep; 38(9):1109-1122. PubMed ID: 28544272
[TBL] [Abstract][Full Text] [Related]
18. CAGI, the Critical Assessment of Genome Interpretation, establishes progress and prospects for computational genetic variant interpretation methods.
Critical Assessment of Genome Interpretation Consortium
Genome Biol; 2024 Feb; 25(1):53. PubMed ID: 38389099
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the inhibitory effects of three transcriptional variants of CDKN2A in human lung cancer cell line A549.
Zhang W; Zhu J; Bai J; Jiang H; Liu F; Liu A; Liu P; Ji G; Guan R; Sun D; Ji W; Yu Y; Jin Y; Meng X; Fu S
J Exp Clin Cancer Res; 2010 Jun; 29(1):74. PubMed ID: 20565749
[TBL] [Abstract][Full Text] [Related]
20. Lessons from the CAGI-4 Hopkins clinical panel challenge.
Chandonia JM; Adhikari A; Carraro M; Chhibber A; Cutting GR; Fu Y; Gasparini A; Jones DT; Kramer A; Kundu K; Lam HYK; Leonardi E; Moult J; Pal LR; Searls DB; Shah S; Sunyaev S; Tosatto SCE; Yin Y; Buckley BA
Hum Mutat; 2017 Sep; 38(9):1155-1168. PubMed ID: 28397312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
